Belgium
· Delayed Price · Currency is EUR Onward Medical Statistics
Total Valuation
Onward Medical has a market cap or net worth of EUR 218.23 million. The enterprise value is 203.50 million.
| Market Cap | 218.23M |
| Enterprise Value | 203.50M |
Important Dates
The last earnings date was Wednesday, December 11, 2024.
| Earnings Date | Dec 11, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Onward Medical has 44.63 million shares outstanding. The number of shares has increased by 7.55% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 44.63M |
| Shares Change (YoY) | +7.55% |
| Shares Change (QoQ) | +14.72% |
| Owned by Insiders (%) | 6.45% |
| Owned by Institutions (%) | 16.45% |
| Float | 23.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 9.23 |
| P/TBV Ratio | 26.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.79 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -7.06 |
Financial Position
The company has a current ratio of 3.65, with a Debt / Equity ratio of 0.94.
| Current Ratio | 3.65 |
| Quick Ratio | 3.37 |
| Debt / Equity | 0.94 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.60 |
| Interest Coverage | -38.55 |
Financial Efficiency
Return on equity (ROE) is -133.61% and return on invested capital (ROIC) is -51.63%.
| Return on Equity (ROE) | -133.61% |
| Return on Assets (ROA) | -41.83% |
| Return on Capital (ROIC) | -51.63% |
| Revenue Per Employee | -1,899 |
| Profits Per Employee | -355,061 |
| Employee Count | 99 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +57.74% in the last 52 weeks. The beta is 0.84, so Onward Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | +57.74% |
| 50-Day Moving Average | 4.99 |
| 200-Day Moving Average | 5.02 |
| Relative Strength Index (RSI) | 53.71 |
| Average Volume (20 Days) | 92,637 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Onward Medical had revenue of EUR -188,000 and -35.15 million in losses. Loss per share was -1.09.
| Revenue | -188,000 |
| Gross Profit | -13.63M |
| Operating Income | -35.43M |
| Pretax Income | -35.41M |
| Net Income | -35.15M |
| EBITDA | -35.10M |
| EBIT | -35.43M |
| Loss Per Share | -1.09 |
Balance Sheet
The company has 32.05 million in cash and 17.31 million in debt, giving a net cash position of 14.74 million or 0.33 per share.
| Cash & Cash Equivalents | 32.05M |
| Total Debt | 17.31M |
| Net Cash | 14.74M |
| Net Cash Per Share | 0.33 |
| Equity (Book Value) | 18.35M |
| Book Value Per Share | 0.53 |
| Working Capital | 25.24M |
Cash Flow
In the last 12 months, operating cash flow was -28.68 million and capital expenditures -159,000, giving a free cash flow of -28.84 million.
| Operating Cash Flow | -28.68M |
| Capital Expenditures | -159,000 |
| Free Cash Flow | -28.84M |
| FCF Per Share | -0.65 |
Margins
| Gross Margin | n/a |
| Operating Margin | 18,846.81% |
| Pretax Margin | 18,833.51% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Onward Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.55% |
| Shareholder Yield | -7.55% |
| Earnings Yield | -22.25% |
| FCF Yield | -13.22% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Onward Medical has an Altman Z-Score of -3.84. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.84 |
| Piotroski F-Score | n/a |